Kura Oncology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 4 | -$0.63 | -$0.63 | -$0.63 |
| Q2 2024 | 3 | -$0.63 | -$0.63 | -$0.63 |
| Q3 2024 | 8 | -$0.70 | -$0.48 | -$0.60 |
| Q1 2025 | 3 | -$0.73 | -$0.63 | -$0.68 |
| Q2 2025 | 2 | -$0.71 | -$0.71 | -$0.71 |
| Q3 2025 | 2 | -$0.74 | -$0.74 | -$0.74 |
| Q4 2025 | 2 | -$0.69 | -$0.69 | -$0.69 |
Kura Oncology, Inc. Earnings Date And Information
Kura Oncology, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.63 earnings per share for the quarter, topping analysts' consensus estimates of $-0.64 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Kura Oncology, Inc. has generated $-2 earnings per share over the last year ($-2.08 diluted earnings per share) and currently has a price-to-earnings ratio of -4.78. Kura Oncology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Kura Oncology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.64 | -$0.63 | 0.01 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.63 | -$0.59 | 0.04 | $0 | $0 |
| 05/02/2024 | Q1 2024 | -$0.56 | -$0.59 | -0.03 | $0 | |
| 02/27/2024 | Q4 2023 | -$0.56 | -$0.55 | 0.01 | $1.27 M | |
| 11/02/2023 | Q3 2023 | -$0.56 | -$0.50 | 0.06 | $0 | |
| 08/09/2023 | Q2 2023 | -$0.53 | $0 | |||
| 05/10/2023 | Q1 2023 | -$0.54 | -$0.45 | 0.09 | $0 | |
| 02/23/2023 | Q4 2022 | -$0.58 | -$0.49 | 0.09 | $0 | |
| 11/03/2022 | Q3 2022 | -$0.57 | -$0.53 | 0.04 | $0 | |
| 08/03/2022 | Q2 2022 | -$0.52 | -$0.53 | -0.01 | $0 | |
| 05/04/2022 | Q1 2022 | -$0.52 | -$0.49 | 0.03 | $0 | |
| 02/24/2022 | Q4 2021 | -$0.54 | -$0.49 | 0.05 | $0 | |
| 11/04/2021 | Q3 2021 | -$0.54 | -$0.50 | 0.04 | $0 | |
| 08/05/2021 | Q2 2021 | -$0.49 | -$0.51 | -0.02 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.42 | -$0.46 | -0.04 | $0 | |
| 02/24/2021 | Q4 2020 | -$0.45 | -$0.45 | 0 | $0 | |
| 11/05/2020 | Q3 2020 | -$0.39 | -$0.42 | -0.03 | $0 | |
| 08/06/2020 | Q2 2020 | -$0.42 | -$0.40 | 0.02 | $0 | |
| 05/04/2020 | Q1 2020 | -$0.42 | -$0.42 | 0 | $0 | |
| 02/25/2020 | Q4 2019 | -$0.42 | -$0.39 | 0.03 | $0 |
Kura Oncology, Inc. Earnings: Frequently Asked Questions
-
When is Kura Oncology, Inc.'s earnings date?
Kura Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
Did Kura Oncology, Inc. beat their earnings estimates last quarter?
In the previous quarter, Kura Oncology, Inc. (:KURA) reported $-0.63 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.64 by $0.01.
-
How can I listen to Kura Oncology, Inc.'s earnings conference call?
The conference call for Kura Oncology, Inc.'s latest earnings report can be listened to online.
-
How can I read Kura Oncology, Inc.'s conference call transcript?
The conference call transcript for Kura Oncology, Inc.'s latest earnings report can be read online.
-
How much profit does Kura Oncology, Inc. generate each year?
Kura Oncology, Inc. (:KURA) has a recorded net income of $0. Kura Oncology, Inc. has generated $-2.08 earnings per share over the last four quarters.
-
What is Kura Oncology, Inc.'s price-to-earnings ratio?
Kura Oncology, Inc. (:KURA) has a price-to-earnings ratio of -4.78 and price/earnings-to-growth ratio is 0.82.
